Delivery of a multivalent scrambled antigen vaccine induces broad spectrum immunity and protection against tuberculosis

Date

2011

Authors

West, Nicholas P
Thomson, Scott
Triccas, James A
Medveczky, C
Ramshaw, Ian
Britton, Warwick

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier

Abstract

The development of effective anti-Tuberculosis (TB) vaccines is an important step towards improved control of TB in high burden countries. Subunit vaccines are advantageous in terms of safety, particularly in the context of high rates of HIV co-infection, but they must contain sufficient Mycobacterium tuberculosis antigens to stimulate immunity in genetically diverse human populations. We have used a novel approach to develop a synthetic scrambled antigen vaccine (TB-SAVINE), comprised of overlapping, recombined peptides from four M. tuberculosis proteins, Ag85B, ESAT-6, PstS3 and Mpt83, each of which is immunogenic and protective against experimental TB. This polyvalent TB-SAVINE construct stimulated CD4 and CD8T cell responses against the individual proteins and M. tuberculosis in C57BL/6 and Balb/c mice, when delivered as DNA, Fowl Pox Virus or Vaccinia Virus vaccines. In addition, the DNA-TBS vaccine induced protective immunity against pulmonary M. tuberculosis infection in C57BL/6 mice. Co-immunization of Balb/c mice with virally expressed TBS and HIV1-SAVINE vaccine stimulated strong T cell responses to both the M. tuberculosis and HIV proteins, indicating no effects of antigenic competition. Further development of this TB-SAVINE vaccine expressing components from multiple M. tuberculosis proteins may prove an effective vaccine candidate against TB, which could potentially form part of a safe, combined preventative strategy together with HIV immunisations.

Description

Keywords

Keywords: bacterial protein; CD4 antigen; DNA vaccine; Human immunodeficiency virus protein; Human immunodeficiency virus vaccine; vaccinia vaccine; article; bacterial immunity; CD8+ T lymphocyte; controlled study; female; Fowlpox virus; Human immunodeficiency viru Coimmunization; HIV; Savine; Tuberculosis; Vaccine

Citation

Source

Vaccine

Type

Journal article

Book Title

Entity type

Access Statement

License Rights

Restricted until

2037-12-31